Cargando…

Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility

Complex karyotype (CK) is a poor prognosis factor in hematological malignancies. Studies have shown that the presence of CK in myelodysplastic syndrome (MDS) can be associated with MDS progression to acute myeloid leukemia. The goal of this review was to examine the relationship between different ty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahjahani, Mohammad, Hadad, Elham Homaei, Azizidoost, Shirin, Nezhad, Kowsar Chenani, Shahrabi, Saeid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379782/ https://www.ncbi.nlm.nih.gov/pubmed/30858933 http://dx.doi.org/10.4081/oncol.2019.389

Ejemplares similares

Vitamin D and its receptor polymorphisms: New possible prognostic biomarkers in leukemias
por: Pezeshki, Seyed Mohammad Sadegh, et al.
Publicado: (2018)

Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights
por: Shahrabi, Saeid, et al.
Publicado: (2016)

Dysplastic eosinophils in myelodysplastic syndrome: association with complex karyotypes
por: Gupta, Ruchi, et al.
Publicado: (2016)

Expression of CD markers in JAK2(V617F) positive myeloproliferative neoplasms: Prognostic significance
por: Shahrabi, Saeid, et al.
Publicado: (2018)

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
por: Haase, Detlef, et al.
Publicado: (2019)

Monosomal and complex karyotypes as prognostic parameters in patients with International Prognostic Scoring System higher risk myelodysplastic syndrome treated with azacitidine
por: Hwang, Kyung-Lim, et al.
Publicado: (2014)

When karyotype is decisive for myelodysplastic syndromes diagnosis
por: Perazzio, Aline dos Santos Borgo, et al.
Publicado: (2019)

Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype
por: Mallo, Mar, et al.
Publicado: (2023)

Bone Marrow Blood Vessels: Normal and Neoplastic Niche
por: Shahrabi, Saeid, et al.
Publicado: (2016)

Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q Deletion
por: Feurstein, Simone, et al.
Publicado: (2018)

Diagnostics and Prognostication of Myelodysplastic Syndromes
por: Zini, Gina
Publicado: (2017)

Somatic mutations predict prognosis in myelodysplastic syndrome patients with normal karyotypes
por: Zeng, Xiangzong, et al.
Publicado: (2021)

Molecular Regulation of Bone Marrow Metastasis in Prostate and Breast Cancer
por: Rahim, Fakher, et al.
Publicado: (2014)

Genomic variations in patients with myelodysplastic syndrome and karyotypes without numerical or structural changes
por: Ribeiro, Cristiano Luiz, et al.
Publicado: (2021)

BRAF Mutation in Hairy Cell Leukemia
por: Ahmadzadeh, Ahmad, et al.
Publicado: (2014)

Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromes
por: Slovak, Marilyn L, et al.
Publicado: (2010)

PB1914: CYTOGENETIC FINDINGS IN 18 CHILDREN WITH MYELODYSPLASTIC SYNDROMES BY KARYOTYPIC AND FISH ANALYSIS
por: Manola, K., et al.
Publicado: (2022)

PB2013: THE FREQUENCY, EVOLUTION AND SIGNIFICANCE OF GENE MUTATION IN MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE
por: Xu, Feng, et al.
Publicado: (2023)

Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic and prognostic biomarkers in colorectal cancer
por: Deris Zayeri, Zeinab, et al.
Publicado: (2023)

Targeted Sequencing Informs the Evaluation of Normal Karyotype Cytopenic Patients for Low-Grade Myelodysplastic Syndrome
por: Duncavage, Eric J., et al.
Publicado: (2016)

Pregnancy outcomes of normal karyotype fetuses with increased nuchal translucency
por: Niroomanesh, Shirin, et al.
Publicado: (2023)

Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia
por: Cavallari, Maurizio, et al.
Publicado: (2018)

Karyotype and DNA-Methylation Responses in Myelodysplastic Syndromes following Treatment with Traditional Chinese Formula Containing Arsenic
por: Shuzhen, Sun, et al.
Publicado: (2012)

Clinico-Pathological Spectrum and Novel Karyotypic Findings in Myelodysplastic Syndrome: Experience of Tertiary Care Center in India
por: Gupta, Ruchi, et al.
Publicado: (2017)

Copper and Zinc Levels in Myelodysplastic Syndrome Patients versus Healthy Subjects
por: Moazed, Vahid, et al.
Publicado: (2020)

Cytokine expression patterns and mesenchymal stem cell karyotypes from the bone marrow microenvironment of patients with myelodysplastic syndromes
por: Xiong, H., et al.
Publicado: (2015)

Certain Autoimmune Manifestations Are Associated With Distinctive Karyotypes and Outcomes in Patients With Myelodysplastic Syndrome: A Retrospective Cohort Study
por: Lee, Sang Jin, et al.
Publicado: (2016)

Prognostic Markers of Myelodysplastic Syndromes
por: Veryaskina, Yuliya Andreevna, et al.
Publicado: (2020)

Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
por: He, Rong, et al.
Publicado: (2022)

Karyotype complexity and prognosis in acute myeloid leukemia
por: Stölzel, F, et al.
Publicado: (2016)

CD markers polymorphisms as prognostic biomarkers in hematological malignancies
por: Shahrabi, Saeid, et al.
Publicado: (2020)

Multiplex ligation-dependent probe amplification assay identifies additional copy number changes compared with R-band karyotype and provide more accuracy prognostic information in myelodysplastic syndromes
por: Wang, Jingya, et al.
Publicado: (2016)

The Evolving Landscape of Myelodysplastic Syndrome Prognostication
por: Shreve, Jacob, et al.
Publicado: (2020)

Identifying the similarities and differences between single nucleotide polymorphism array (SNPa) analysis and karyotyping in acute myeloid leukemia and myelodysplastic syndromes
por: Noronha, Thiago Rodrigo de, et al.
Publicado: (2015)

Thrombocytopenia in solid tumors: Prognostic significance
por: Ghanavat, Majid, et al.
Publicado: (2019)

Identification of miR-320 family members as potential diagnostic and prognostic biomarkers in myelodysplastic syndromes
por: Wan, Chengyao, et al.
Publicado: (2021)

Myelodysplastic Syndromes with Isolated del(5q): Value of Molecular Alterations for Diagnostic and Prognostic Assessment
por: Acha, Pamela, et al.
Publicado: (2022)

P440: ENHANCER HIJACKING IN COMPLEX-KARYOTYPE AML
por: Sollier, Etienne, et al.
Publicado: (2023)

Prognostic significance of aberrant CD5 expression in B-cell leukemia
por: Jaseb, Kaveh, et al.
Publicado: (2019)

Role of conventional cytogenetics in sequential karyotype analysis of myelodysplastic syndrome: a patient with der(1;7)(q10;p10)
por: França, Ivo Gabriel da Frota, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h3i87n518ji2j5fn7o4clnskj0